Skip to main content
  • 80 Accesses

Abstract

The principles underlying the administration of cytotoxic drugs for the treatment of malignant disease differ fundamentally from those of bacterial, fungal, or antiviral infections in that it is not possible to administer a drug that is toxic only to the tumour and therefore some adverse affects on the host are inevitable. The therapeutic ratio is often close to unity and in such circumstances treatment must produce some toxicity in order to induce a worthwhile regression of the tumour. Similarly, the difference between successful therapy and severe or even fatal iatrogenic effects may depend on only minor dose adjustments. It is of the utmost importance therefore to understand those factors which influence response to therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Benjamin RS, Wiernik PH, Bachur NR (1974) Adriamycin chemotherapy—efficacy, safety and pharmacologic basis of an intermittent single high-dose schedule. Cancer 33: 19–27

    Article  PubMed  CAS  Google Scholar 

  • Cannellos GP, De Vita VT, Gold LG, Chabner BA, Schein PS, Young RC (1974) Cyclical combination chemotherapy for advanced breast carcinoma. Br Med J I: 218–220

    Article  Google Scholar 

  • Einhorn LH, Donohue J (1977) Cis-diamminodichloroplatinum vinblastine and bleomycin chemotherapy in disseminated testicular cancer. Ann Intern Med 87: 293–298

    PubMed  CAS  Google Scholar 

  • Frei E III (1972) Combination cancer chemotherapy. Presidentialaddress. Cancer Res 32: 2595

    Google Scholar 

  • Henderson ES, Adamson RH, Oliverio VT (1965) The metabolic fate of tritiated methotrexate. Absorption and excretion in man. Cancer Res 25: 1018–1024

    PubMed  CAS  Google Scholar 

  • Jones SE, Durie BGM, Salmon SE (1975) Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancer. Cancer 36: 90–97

    Article  PubMed  CAS  Google Scholar 

  • Pacciarini MA, Barbieri B, Colombo T, Broggini M, Garattini S, Donelli MG (1978) Distribution and anti-tumour activity of adriamycin given in a high dose and a repeated low-dose schedule in mice. Cancer Treat Rep 62: 791

    PubMed  CAS  Google Scholar 

  • Skipper HE (1965) The effects of chemotherapy on the kinetics of leukaemia cell behaviour. Cancer Res 25: 1544

    PubMed  CAS  Google Scholar 

  • Thatcher N, Parker PV, Hunter RD, Carroll KB, Jegarajah S, Wilkinson PM, Crowther D (1982) 11-week course of sequential methotrexate, thoracic irradiation and moderate-dose cyclophosphamide for ‘limited-stage’ small-cell bron-chiogenic carcinoma. Lancet II: 1040–1042

    Article  Google Scholar 

Further Reading

  • Chabner B (ed) (1982) Pharmacologic principles of cancer treatment. Saunders, Philadelphia

    Google Scholar 

  • Pinedo HM (ed) (1983) Cancer chemotherapy. Excerpta Medica, Amsterdam

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Wilkinson, P.M., Fox, B.W. (1985). Principles of Chemotherapy. In: Easson, E.C., Pointon, R.C.S. (eds) The Radiotherapy of Malignant Disease. Springer, London. https://doi.org/10.1007/978-1-4471-3322-3_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-3322-3_3

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-3324-7

  • Online ISBN: 978-1-4471-3322-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics